Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators.
Journal:
The European respiratory journal
PMID:
34266943
Abstract
BACKGROUND: Chest computed tomography (CT) remains the imaging standard for demonstrating cystic fibrosis (CF) airway structural disease . However, visual scoring systems as an outcome measure are time consuming, require training and lack high reproducibility. Our objective was to validate a fully automated artificial intelligence (AI)-driven scoring system of CF lung disease severity.